Understanding and replicating the organ-to-organ protocols is a complex subject . It is more about the chemical reactions especially organic chemical reactions.
How the role of hormones ,which are the stimulator s for these chemical interactions , affects the interrelationship is the main thing that the researchers will have to decode , digitize and program to be able to exactly simulate the organ functionality in the lab.
MIT is doing a great job here as the progress in this area will lead to speeding up of many clinical trials without the need of human or animal guinea pigs
Thanks for your very informative article. But with IoT, I don't see a major problem that cannot be fixed. Just like the early years of computer networking, things will improve and a standard will be revealed because the underline topic is profit. Yes, I agree that it will be challenging at first, but I don't really see a major problem that cannot be fixed in this area.
As we unveil EE Times’ 2015 Silicon 60 list, journalist & Silicon 60 researcher Peter Clarke hosts a conversation on startups in the electronics industry. Panelists Dan Armbrust (investment firm Silicon Catalyst), Andrew Kau (venture capital firm Walden International), and Stan Boland (successful serial entrepreneur, former CEO of Neul, Icera) join in the live debate.